The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Roche is reported to be considering the sale of its cancer data specialist Flatiron Health, just a few years after it bought the company for $1.9 billion. The Financial Times first revealed the ...

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

Good thing I’m not their boss. They would be gone. I have used Quest Diagnostics for over two years. My results are important to me due to the fact that I have a kidney transplant. It is very ...

After hours: November 15 at 7:54 PM EST Loading Chart for CODX ...

After hours: November 15 at 6:24 PM EST Loading Chart for LUCD ...

Future of HealthMerck says Keytruda injection on par with approved IV version in trial Merck said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the ...

To run the app without installing, download Standalone.zip below, unzip, then run SidebarDiagnostics.exe. Please note that the Standalone build will not auto-update.